CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 15 filers reported holding CLOVIS ONCOLOGY INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $167,000 | -7.2% | 140,616 | +40.5% | 0.00% | 0.0% |
| Q2 2022 | $180,000 | -10.9% | 100,100 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $202,000 | -29.4% | 100,100 | -5.3% | 0.00% | -33.3% |
| Q4 2021 | $286,000 | -39.1% | 105,700 | +0.1% | 0.00% | -25.0% |
| Q3 2021 | $470,000 | +1368.8% | 105,600 | +1785.7% | 0.00% | – |
| Q2 2021 | $32,000 | -30.4% | 5,600 | -15.2% | 0.00% | – |
| Q1 2021 | $46,000 | -98.1% | 6,600 | -98.7% | 0.00% | -100.0% |
| Q4 2020 | $2,406,000 | -16.6% | 501,413 | +1.2% | 0.02% | -32.0% |
| Q3 2020 | $2,886,000 | -13.6% | 495,313 | 0.0% | 0.02% | -26.5% |
| Q2 2020 | $3,342,000 | -38.7% | 495,313 | -42.3% | 0.03% | -57.5% |
| Q1 2020 | $5,456,000 | -29.7% | 858,013 | +15.2% | 0.08% | -11.1% |
| Q4 2019 | $7,761,000 | +310.4% | 744,600 | +54.7% | 0.09% | +275.0% |
| Q3 2019 | $1,891,000 | +43.0% | 481,300 | +440.8% | 0.02% | +33.3% |
| Q2 2019 | $1,322,000 | -48.9% | 89,000 | -14.6% | 0.02% | -48.6% |
| Q1 2019 | $2,585,000 | +463.2% | 104,200 | +306.0% | 0.04% | +600.0% |
| Q4 2018 | $459,000 | +7.7% | 25,664 | +76.2% | 0.01% | 0.0% |
| Q3 2018 | $426,000 | -40.8% | 14,564 | -8.2% | 0.01% | -50.0% |
| Q2 2018 | $719,000 | +35.9% | 15,860 | +57.8% | 0.01% | +42.9% |
| Q1 2018 | $529,000 | -69.9% | 10,050 | -61.1% | 0.01% | -61.1% |
| Q4 2017 | $1,758,000 | -31.7% | 25,863 | -17.2% | 0.02% | -35.7% |
| Q3 2017 | $2,573,000 | -40.8% | 31,235 | -32.7% | 0.03% | -49.1% |
| Q2 2017 | $4,343,000 | +27.5% | 46,400 | -13.3% | 0.06% | +3.8% |
| Q1 2017 | $3,406,000 | +74.3% | 53,500 | +21.6% | 0.05% | +112.0% |
| Q4 2016 | $1,954,000 | +181.6% | 44,000 | +128.2% | 0.02% | +127.3% |
| Q3 2016 | $694,000 | +37.7% | 19,284 | -47.6% | 0.01% | +57.1% |
| Q2 2016 | $504,000 | -49.2% | 36,784 | +25623.1% | 0.01% | -75.0% |
| Q1 2016 | $992,000 | +11.7% | 143 | -20.1% | 0.03% | +47.4% |
| Q4 2015 | $888,000 | +77.2% | 179 | 0.0% | 0.02% | +58.3% |
| Q3 2015 | $501,000 | +8250.0% | 179 | +70.5% | 0.01% | – |
| Q2 2015 | $6,000 | -66.7% | 105 | -48.8% | 0.00% | – |
| Q1 2015 | $18,000 | -56.1% | 205 | 0.0% | 0.00% | -100.0% |
| Q4 2014 | $41,000 | – | 205 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 3,997,826 | $10,834,000 | 0.69% |
| Ikarian Capital, LLC | 1,112,669 | $3,016,000 | 0.45% |
| Versant Venture Management, LLC | 101,855 | $276,000 | 0.15% |
| Virtus ETF Advisers LLC | 60,836 | $165,000 | 0.06% |
| EMFO, LLC | 21,500 | $58,000 | 0.05% |
| QVT Financial LP | 505,000 | $1,369,000 | 0.05% |
| QVT Financial LP | 505,000 | $1,369,000 | 0.05% |
| PINNACLE ASSOCIATES LTD | 706,336 | $1,914,000 | 0.03% |
| XTX Topco Ltd | 20,920 | $57,000 | 0.03% |
| State of Wyoming | 25,419 | $69,000 | 0.03% |